These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27351762)

  • 1. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
    Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
    Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of Molecular Probes Based on Iron Oxide Nanoparticles for in Vivo Magnetic Resonance/Photoacoustic Dual Imaging of Target Molecules in Tumors].
    Sano K
    Yakugaku Zasshi; 2017; 137(1):55-60. PubMed ID: 28049896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer.
    Chen H; Wang L; Yu Q; Qian W; Tiwari D; Yi H; Wang AY; Huang J; Yang L; Mao H
    Int J Nanomedicine; 2013; 8():3781-94. PubMed ID: 24124366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging.
    Kanazaki K; Sano K; Makino A; Shimizu Y; Yamauchi F; Ogawa S; Ding N; Yano T; Temma T; Ono M; Saji H
    Nanomedicine; 2015 Nov; 11(8):2051-60. PubMed ID: 26238078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes.
    Alric C; Hervé-Aubert K; Aubrey N; Melouk S; Lajoie L; Même W; Même S; Courbebaisse Y; Ignatova AA; Feofanov AV; Chourpa I; Allard-Vannier E
    J Nanobiotechnology; 2018 Feb; 16(1):18. PubMed ID: 29466990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Gold Nanorods Conjugated with Radiolabeled Anti-human Epidermal Growth Factor Receptor 2 (HER2) Monoclonal Antibody as Single-Photon Emission Computed Tomography/Photoacoustic Dual-Imaging Probes Targeting HER2-Positive Tumors.
    Ding N; Sano K; Shimizu Y; Watanabe H; Namita T; Shiina T; Ono M; Saji H
    Biol Pharm Bull; 2020; 43(12):1859-1866. PubMed ID: 33268703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab and near infrared probe conjugated iron oxide nanoparticles for vascular endothelial growth factor targeted MR and optical imaging.
    Lin R; Huang J; Wang L; Li Y; Lipowska M; Wu H; Yang J; Mao H
    Biomater Sci; 2018 May; 6(6):1517-1525. PubMed ID: 29652061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.
    Daldrup-Link HE; Meier R; Rudelius M; Piontek G; Piert M; Metz S; Settles M; Uherek C; Wels W; Schlegel J; Rummeny EJ
    Eur Radiol; 2005 Jan; 15(1):4-13. PubMed ID: 15616814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI.
    Adolphi NL; Butler KS; Lovato DM; Tessier TE; Trujillo JE; Hathaway HJ; Fegan DL; Monson TC; Stevens TE; Huber DL; Ramu J; Milne ML; Altobelli SA; Bryant HC; Larson RS; Flynn ER
    Contrast Media Mol Imaging; 2012; 7(3):308-19. PubMed ID: 22539401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional superparamagnetic nanoparticles conjugated with fluorescein-labeled designed ankyrin repeat protein as an efficient HER2-targeted probe in breast cancer.
    Li DL; Tan JE; Tian Y; Huang S; Sun PH; Wang M; Han YJ; Li HS; Wu HB; Zhang XM; Xu YK; Wang QS
    Biomaterials; 2017 Dec; 147():86-98. PubMed ID: 28938164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of tumor with a self-traceable polymer conjugated with an antibody fragment.
    Yamada H; Hasegawa Y; Suzuki Y; Imai H; Matsuda T; Kimura Y; Toshimitsu A; Aoyama Y; Kondo T
    Bioorg Med Chem Lett; 2015 Jul; 25(13):2675-8. PubMed ID: 25958246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeled ultra-small Fe
    Sun H; Zhang B; Jiang X; Liu H; Deng S; Li Z; Shi H
    Nanomedicine (Lond); 2019 Jan; 14(1):5-17. PubMed ID: 30451578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer.
    Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S
    Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents.
    Funovics MA; Kapeller B; Hoeller C; Su HS; Kunstfeld R; Puig S; Macfelda K
    Magn Reson Imaging; 2004 Jul; 22(6):843-50. PubMed ID: 15234453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo.
    Guan SS; Wu CT; Chiu CY; Luo TY; Wu JY; Liao TZ; Liu SH
    J Transl Med; 2018 Jun; 16(1):168. PubMed ID: 29921305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.
    Bouras A; Kaluzova M; Hadjipanayis CG
    J Neurooncol; 2015 Aug; 124(1):13-22. PubMed ID: 25981803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insight about Biocompatibility and Biodegradability of Iron Oxide Magnetic Nanoparticles: Stereological and In Vivo MRI Monitor.
    Nosrati H; Salehiabar M; Fridoni M; Abdollahifar MA; Kheiri Manjili H; Davaran S; Danafar H
    Sci Rep; 2019 May; 9(1):7173. PubMed ID: 31073222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
    Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
    J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive Photoacoustic/Magnetic Resonance Dual Imaging Probe for Detection of Malignant Tumors.
    Ding N; Sano K; Kanazaki K; Shimizu Y; Watanabe H; Namita T; Shiina T; Ono M; Saji H
    J Pharm Sci; 2020 Oct; 109(10):3153-3159. PubMed ID: 32679213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers.
    Lazaro-Carrillo A; Filice M; Guillén MJ; Amaro R; Viñambres M; Tabero A; Paredes KO; Villanueva A; Calvo P; Del Puerto Morales M; Marciello M
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110262. PubMed ID: 31761230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.